Blood Clot Retrieval Device Market to Reach USD 9.88 Billion by 2035 | North America Holds 42.8% Market Share | Key Players: Medtronic, Stryker, Penumbra

The global blood clot retrieval device market was valued at USD 2.61 billion in 2025 and is projected to reach USD 9.88 billion by 2035, growing at a CAGR of 14.19% during the forecast period from 2026 to 2035. The market is experiencing rapid growth driven by the increasing prevalence of ischemic stroke, deep vein thrombosis, pulmonary embolism, and other thromboembolic disorders worldwide. Growing awareness regarding the benefits of early intervention, rising adoption of minimally invasive procedures, and expanding availability of advanced neurovascular treatment centers are significantly contributing to market expansion. Favorable clinical outcomes for mechanical thrombectomy, increased healthcare investment, and ongoing advances in interventional radiology and neurovascular technologies are creating strong long-term growth opportunities in both developed and emerging healthcare markets.

The market is undergoing a significant transformation from standalone thrombectomy devices to comprehensive clot-retrieval platforms focused on improving procedural efficiency and patient outcomes. Healthcare providers are increasingly adopting aspiration-first approaches, large-bore catheter systems, and combined mechanical thrombectomy techniques that offer faster reperfusion rates, enhanced clot removal efficiency, improved vessel navigability, and reduced procedural complications. Leading companies, including Stryker Corporation, Medtronic plc, Penumbra, Inc., Johnson & Johnson MedTech, and Terumo Corporation, are actively investing in next-generation thrombectomy systems, aspiration technologies, and integrated stroke treatment solutions to strengthen their market position. Rising demand for rapid stroke intervention, expanding clinical evidence supporting mechanical thrombectomy, and increasing adoption of advanced endovascular procedures are expected to drive sustained growth in the global blood clot retrieval device market over the forecast period.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/blood-clot-retrieval-device-market?sai-v

Key Developments

April 2026: The United States increased investments in stroke care infrastructure and neurovascular treatment technologies, supporting wider adoption of blood clot retrieval devices for the treatment of acute ischemic stroke and other thrombotic conditions.

March 2026: Japan strengthened initiatives focused on advanced neurointerventional procedures and minimally invasive stroke treatment, driving demand for next-generation blood clot retrieval devices across major healthcare facilities.

February 2026: Stryker Corporation expanded innovation efforts in mechanical thrombectomy technologies, enhancing clot retrieval performance and supporting improved patient outcomes in acute stroke interventions.

January 2026: Healthcare providers increased investments in comprehensive stroke centers and neurovascular treatment programs, accelerating adoption of advanced clot retrieval systems and associated imaging technologies.

December 2025: Medical device manufacturers accelerated research and development activities focused on improving clot engagement, navigation capabilities, and procedural efficiency in thrombectomy devices.

November 2025: Penumbra, Inc. strengthened its neurovascular portfolio through advancements in aspiration-based thrombectomy technologies designed to improve clot removal effectiveness and procedural success rates.

October 2025: Industry participants expanded physician training and clinical education programs aimed at increasing utilization of mechanical thrombectomy procedures and improving stroke treatment accessibility.

September 2025: India increased investments in stroke management infrastructure and emergency neurovascular care services, supporting broader access to advanced clot retrieval procedures in tertiary healthcare centers.

July 2025: Medtronic plc advanced development of neurovascular intervention technologies, supporting enhanced treatment options for patients experiencing acute ischemic stroke.

May 2025: Healthcare institutions accelerated adoption of minimally invasive stroke treatment approaches, increasing demand for stent retrievers, aspiration catheters, and integrated thrombectomy platforms.

March 2025: Strategic collaborations between hospitals, research institutions, and medical device manufacturers expanded clinical research efforts focused on improving thrombectomy outcomes and reducing stroke-related disability.

January 2025: Governments across North America, Europe, and Asia-Pacific strengthened investments in stroke awareness, emergency response systems, and neurovascular healthcare infrastructure, supporting long-term growth of the blood clot retrieval device market.

Key Players

Medtronic | Stryker | Penumbra, Inc. | Johnson & Johnson MedTech | Terumo Neuro | Others

Key Highlights

Medtronic - Holds a 24.8% share, driven by its extensive neurovascular portfolio, strong global distribution network, advanced mechanical thrombectomy technologies, and continued innovation in stroke intervention solutions.

Stryker - Holds a 22.1% share, supported by its widely adopted neurovascular products, robust physician relationships, and strong presence in acute ischemic stroke treatment procedures worldwide.

Penumbra, Inc. - Holds a 19.3% share, strengthened by its aspiration-based thrombectomy systems, continuous product innovation, and growing adoption of minimally invasive stroke treatment technologies.

Johnson & Johnson MedTech - Holds a 14.6% share, fueled by advanced neurovascular intervention solutions, significant research and development investments, and a broad global healthcare footprint.

Terumo Neuro - Holds a 9.8% share, supported by specialized neurovascular devices, strong clinical adoption across key markets, and expanding product offerings for stroke management.

Others - Hold a combined 9.4% share, comprising regional neurovascular device manufacturers, emerging thrombectomy technology providers, and specialized stroke intervention companies.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=blood-clot-retrieval-device-market?sai-v

Market Drivers

Increasing prevalence of ischemic stroke, cardiovascular disorders, and neurovascular diseases is significantly driving growth of the blood clot retrieval device market worldwide.

Growing adoption of mechanical thrombectomy procedures as a standard treatment for acute ischemic stroke is accelerating demand for advanced clot retrieval technologies globally.

Rising aging population and increasing incidence of lifestyle-related risk factors such as hypertension, diabetes, obesity, and atrial fibrillation are strengthening market expansion.

Advancements in minimally invasive neurovascular interventions and image-guided treatment procedures are improving clinical outcomes and encouraging wider adoption of clot retrieval devices.

Expansion of comprehensive stroke centers, neurointerventional facilities, and emergency stroke treatment networks is increasing accessibility to thrombectomy procedures.

Growing awareness regarding the importance of rapid stroke intervention and improved patient outcomes is supporting higher utilization of blood clot retrieval solutions.

Continuous innovation in stent retrievers, aspiration catheters, guidewires, and neurovascular access systems is enhancing procedural success rates and treatment efficiency.

Increasing investments from healthcare providers, medical device manufacturers, and governments in stroke care infrastructure and neurovascular treatment capabilities are further propelling market growth.

Industry Developments

Rapid advancement in next-generation thrombectomy technologies improving clot engagement, navigation capabilities, procedural speed, and recanalization outcomes.

Increasing adoption of aspiration-first techniques and combined thrombectomy approaches supporting more effective stroke intervention strategies.

Growing investments in artificial intelligence-assisted imaging, stroke diagnosis platforms, and workflow optimization technologies accelerating innovation across the neurovascular ecosystem.

Expansion of clinical research activities and real-world evidence studies improving treatment protocols and supporting broader adoption of mechanical thrombectomy procedures.

Rising collaborations among medical device manufacturers, hospitals, stroke centers, and research institutions driving development of advanced neurovascular treatment solutions.

Strategic product launches, regulatory approvals, and manufacturing capacity expansions supporting global market expansion and improved patient access.

Continuous innovation in catheter design, stent retriever technologies, aspiration systems, and neurovascular navigation devices improving treatment effectiveness and procedural safety.

Regional Insights

North America 42.8% share: "Leads the market due to advanced stroke care infrastructure, high adoption of mechanical thrombectomy procedures, strong reimbursement systems, and significant investments in neurovascular technologies across the United States and Canada."

Europe 29.6% share: "Growth supported by expanding stroke treatment networks, favorable clinical guidelines, increasing awareness of acute stroke intervention, and strong healthcare infrastructure."

Asia Pacific 20.1% share: "Rapid expansion driven by rising stroke incidence, growing healthcare expenditure, increasing establishment of stroke centers, and improving access to advanced neurovascular procedures across China, Japan, India, and South Korea."

Latin America 4.2% share: "Growth supported by improving healthcare facilities, increasing awareness of stroke treatment options, and gradual adoption of advanced neurovascular intervention technologies."

Middle East & Africa 3.3% share: "Gradual growth driven by healthcare modernization initiatives, expanding neurological care services, increasing investments in medical technologies, and improving access to stroke treatment infrastructure."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-clot-retrieval-device-market?sai-v

Key Segments
➥ By Product Type

Stent Retrievers: Represents the dominant segment, driven by their high success rates in mechanical thrombectomy procedures and widespread adoption for the treatment of acute ischemic stroke.

Aspiration Catheters: Represents a significant segment, supported by increasing preference for aspiration-first techniques due to procedural efficiency, rapid clot removal, and favorable clinical outcomes.

Guidewires & Microcatheters: Represents a major segment, fueled by their essential role in navigating vascular pathways and supporting clot retrieval procedures.

Balloon Guide Catheters: Represents a growing segment, driven by their ability to reduce distal embolization and improve procedural effectiveness during thrombectomy interventions.

Others: Represents a moderate segment, supported by the introduction of innovative thrombectomy accessories and next-generation clot retrieval technologies.

➥ By Retrieval Technique

Mechanical Thrombectomy: Represents the dominant segment, driven by its proven effectiveness in restoring blood flow in patients experiencing acute ischemic stroke and other thrombotic events.

Aspiration Thrombectomy: Represents a significant segment, supported by increasing utilization of direct aspiration techniques for rapid clot extraction and simplified procedural workflows.

Combined Technique: Represents a rapidly growing segment, fueled by the adoption of combined stent retriever and aspiration approaches to maximize recanalization success rates.

Others: Represents a moderate segment, supported by ongoing technological advancements and the development of specialized clot retrieval methodologies.

➥ By Application / Use Case

Acute Ischemic Stroke: Represents the dominant segment, driven by the rising incidence of stroke and expanding adoption of thrombectomy procedures as the standard of care.

Deep Vein Thrombosis (DVT): Represents a significant segment, supported by increasing demand for minimally invasive clot removal procedures to prevent complications.

Pulmonary Embolism (PE): Represents a major segment, fueled by growing utilization of thrombectomy devices for the treatment of life-threatening pulmonary artery blockages.

Peripheral Arterial Occlusions: Represents a growing segment, driven by increasing prevalence of vascular diseases and demand for effective clot removal solutions.

Others: Represents a moderate segment, supported by expanding applications in neurovascular and cardiovascular interventions.

➥ By Vessel Location

Cerebral Vessels: Represents the dominant segment, driven by the extensive use of clot retrieval devices in neurovascular interventions for acute ischemic stroke treatment.

Peripheral Vessels: Represents a significant segment, supported by increasing treatment of thrombotic blockages in peripheral arteries and veins.

Pulmonary Vessels: Represents a growing segment, fueled by rising adoption of thrombectomy procedures for pulmonary embolism management.

Coronary Vessels: Represents a moderate segment, driven by specialized applications in cardiovascular interventions requiring clot extraction.

➥ By Vessel Compatibility

Large Vessel Devices: Represents the dominant segment, driven by the growing number of large vessel occlusion (LVO) stroke cases and increasing procedural volumes worldwide.

Medium Vessel Devices: Represents a significant segment, supported by expanding clinical evidence and technological advancements enabling treatment of medium vessel occlusions.

Small Vessel Devices: Represents a growing segment, fueled by innovation in miniaturized thrombectomy systems designed for challenging vascular anatomies.

➥ By Usage Type

Single-Use Devices: Represents the dominant segment, driven by stringent infection control requirements, regulatory standards, and the need for optimal device performance.

Reusable Devices: Represents a moderate segment, supported by cost-containment initiatives and utilization in selected healthcare settings where reprocessing is feasible.

➥ By End-User

Hospitals: Represents the dominant segment, driven by the availability of advanced neurovascular and cardiovascular intervention facilities and high procedural volumes.

Specialty Clinics: Represents a significant segment, supported by increasing adoption of minimally invasive vascular treatment procedures in specialized care centers.

Ambulatory Surgical Centers (ASCs): Represents a growing segment, fueled by rising preference for cost-effective outpatient intervention services.

Others: Represents a moderate segment, supported by utilization across research institutions, academic medical centers, and specialty healthcare facilities.

➥ By Procurement Channel

Direct Tenders: Represents the dominant segment, driven by large-volume purchasing agreements between healthcare institutions and medical device manufacturers.

Distributors & Dealers: Represents a significant segment, supported by extensive distribution networks that improve product accessibility across regional markets.

Group Purchasing Organizations (GPOs): Represents a growing segment, fueled by increasing efforts among healthcare providers to optimize procurement costs and supply chain efficiency.

Others: Represents a moderate segment, supported by online procurement platforms, third-party suppliers, and specialized healthcare procurement services.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.